.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Johnson and Johnson
UBS
US Army
US Department of Justice
Cipla
Harvard Business School
Dow
Argus Health

Which pharma companies have the most supplementary protection certificates?

This chart shows the drug companies with the most supplementary protection certificates (SPCs).

SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to obtain regulatory approval for drugs. SPCs come into force only after the corresponding general patent expires, and normally have a maximum lifetime of 5 years.

The total combined duration of market exclusivity of a general patent and SPC cannot normally exceed 15 years, but a six-month extention may be obtained by responding to a request for pediatric trials.

The pharma companies with the most SPCs are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot